Bioleaders Corporation Working Capital to Net Assets Ratio
Bioleaders Corporation working capital to net assets ratio. Bioleaders Corporation (142760) has a Working Capital to Net Assets ratio of 34.1% as of June 2026. Working capital of ₩8.24 Billion (current assets of ₩15.95 Billion minus current liabilities of ₩7.72 Billion) is measured against net assets of ₩24.19 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Bioleaders Corporation (142760) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Bioleaders Corporation (2015–2025)
Working capital to net assets ratio of Bioleaders Corporation from 2015 to 2025. This chart shows how Bioleaders Corporation's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 34.1%, reflecting working capital of ₩8.24 Billion against net assets of ₩24.19 Billion KRW. See 142760 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Bioleaders Corporation Working Capital to Net Assets Ratio by Year (2015–2025)
Bioleaders Corporation working capital to net assets ratio by year from 2015 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Bioleaders Corporation from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Bioleaders Corporation balance sheet assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 49.3% | ₩15.06 Billion | ₩30.57 Billion | ₩26.52 Billion | ₩11.46 Billion | ▼ -19.7 pp |
| 2024 | 69.0% | ₩25.74 Billion | ₩37.31 Billion | ₩46.37 Billion | ₩20.63 Billion | ▲ +20.6 pp |
| 2023 | 48.4% | ₩17.31 Billion | ₩35.79 Billion | ₩29.84 Billion | ₩12.53 Billion | ▲ +17.0 pp |
| 2022 | 31.4% | ₩6.80 Billion | ₩21.69 Billion | ₩71.77 Billion | ₩64.97 Billion | ▼ -80.4 pp |
| 2021 | 111.8% | ₩50.44 Billion | ₩45.11 Billion | ₩97.14 Billion | ₩46.70 Billion | ▲ +78.3 pp |
| 2020 | 33.5% | ₩10.26 Billion | ₩30.60 Billion | ₩73.53 Billion | ₩63.26 Billion | ▲ +17.9 pp |
| 2019 | 15.7% | ₩3.73 Billion | ₩23.82 Billion | ₩66.55 Billion | ₩62.82 Billion | ▲ +52.0 pp |
| 2018 | -36.3% | ₩-8.54 Billion | ₩23.50 Billion | ₩69.23 Billion | ₩77.77 Billion | ▼ -118.7 pp |
| 2017 | 82.4% | ₩28.96 Billion | ₩35.17 Billion | ₩30.91 Billion | ₩1.94 Billion | ▼ -0.5 pp |
| 2016 | 82.9% | ₩14.47 Billion | ₩17.46 Billion | ₩17.67 Billion | ₩3.20 Billion | ▲ +2.8 pp |
| 2015 | 80.1% | ₩4.45 Billion | ₩5.55 Billion | ₩7.90 Billion | ₩3.45 Billion | — |